NO301473B1 - BHT-omega-pyridyleterforbindelser og farmasöytisk preparat inneholdende disse - Google Patents

BHT-omega-pyridyleterforbindelser og farmasöytisk preparat inneholdende disse

Info

Publication number
NO301473B1
NO301473B1 NO942307A NO942307A NO301473B1 NO 301473 B1 NO301473 B1 NO 301473B1 NO 942307 A NO942307 A NO 942307A NO 942307 A NO942307 A NO 942307A NO 301473 B1 NO301473 B1 NO 301473B1
Authority
NO
Norway
Prior art keywords
bht
omega
pharmaceutical compositions
compositions containing
ether compounds
Prior art date
Application number
NO942307A
Other languages
English (en)
Norwegian (no)
Other versions
NO942307D0 (no
NO942307L (no
Inventor
Markus R Gold
Panayiotis Jarglis
Heinz Junglas
Juergen H Leimner
Dezsoe Peteri
Guenter P Quack
Josef Strohmeier
Petra M Wuelfroth
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Publication of NO942307D0 publication Critical patent/NO942307D0/no
Publication of NO942307L publication Critical patent/NO942307L/no
Publication of NO301473B1 publication Critical patent/NO301473B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO942307A 1991-12-19 1994-06-17 BHT-omega-pyridyleterforbindelser og farmasöytisk preparat inneholdende disse NO301473B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/810,214 US5254549A (en) 1991-12-19 1991-12-19 New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
PCT/EP1992/002946 WO1993012089A1 (fr) 1991-12-19 1992-12-18 Nouveaux composes d'ether d'hydroxytoluene butyle (bht) et utilisation de ces composes comme medicaments hypolipidemiants et anti-atherosclerose

Publications (3)

Publication Number Publication Date
NO942307D0 NO942307D0 (no) 1994-06-17
NO942307L NO942307L (no) 1994-06-17
NO301473B1 true NO301473B1 (no) 1997-11-03

Family

ID=25203281

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942307A NO301473B1 (no) 1991-12-19 1994-06-17 BHT-omega-pyridyleterforbindelser og farmasöytisk preparat inneholdende disse

Country Status (16)

Country Link
US (1) US5254549A (fr)
EP (1) EP0619807A1 (fr)
JP (1) JPH07502271A (fr)
AU (1) AU662193B2 (fr)
CA (1) CA2085687A1 (fr)
CZ (1) CZ283456B6 (fr)
FI (1) FI942908A0 (fr)
HU (1) HU215844B (fr)
IL (1) IL104123A (fr)
MX (1) MX9207427A (fr)
NO (1) NO301473B1 (fr)
PL (1) PL171225B1 (fr)
RU (1) RU2120938C1 (fr)
TW (1) TW221289B (fr)
WO (1) WO1993012089A1 (fr)
ZA (1) ZA929867B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677291A (en) * 1993-12-10 1997-10-14 Hoechst Marion Roussel, Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
US5627172A (en) * 1994-03-04 1997-05-06 Natural Supplement Association, Incorporated Method for reduction of serum blood lipids or lipoprotein fraction
US5795876A (en) * 1996-04-30 1998-08-18 Hoechst Marion Rousssel, Inc. Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols
US5608095A (en) * 1996-04-30 1997-03-04 Hoechst Marion Roussel, Inc. Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
US6114572A (en) * 1996-11-20 2000-09-05 Hoechst Marion Roussel, Inc. Substituted phenols and thiophenols useful as antioxidant agents
US6121463A (en) * 1997-06-24 2000-09-19 Hoechst Marion Roussel, Inc. Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents
US6133467A (en) * 1997-06-25 2000-10-17 Hoechst Marion Roussel, Inc. 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol
US6475526B1 (en) 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
RU2216738C2 (ru) * 2001-09-14 2003-11-20 Рагино Юлия Игоревна Способ оценки антиоксидантного потенциала липопротеинов низкой плотности
EP1546105A1 (fr) * 2002-07-17 2005-06-29 Lek Pharmaceutical and Chemical Co. D.D. Nouveaux derives d'amines pyridylethanol (phenylethyl) utiles comme inhibiteurs de la biosynthese du cholesterol, leurs procedes de preparation et compositions pharmaceutiques les contenant
US20080274209A1 (en) * 2002-11-04 2008-11-06 Integritas Pharma, Inc. Methods of treating inflammation
US6855341B2 (en) * 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions
RU2228746C1 (ru) * 2002-11-25 2004-05-20 Хазанов Вениамин Абрамович Антигиперлипидемическое средство (варианты)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE271625C (fr) *
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives
DE3431004A1 (de) * 1984-08-23 1986-03-06 Hoechst Ag, 6230 Frankfurt Neue 3-pyridylverbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IL104123A0 (en) 1993-05-13
HU9401820D0 (en) 1994-09-28
FI942908L (fi) 1994-06-17
RU2120938C1 (ru) 1998-10-27
ZA929867B (en) 1994-06-20
NO942307D0 (no) 1994-06-17
FI942908A7 (fi) 1994-06-17
HUT70398A (en) 1995-10-30
FI942908A0 (fi) 1994-06-17
TW221289B (fr) 1994-02-21
IL104123A (en) 1996-12-05
EP0619807A1 (fr) 1994-10-19
AU662193B2 (en) 1995-08-24
CZ135294A3 (en) 1995-11-15
PL171225B1 (pl) 1997-03-28
NO942307L (no) 1994-06-17
MX9207427A (es) 1993-11-01
CZ283456B6 (cs) 1998-04-15
JPH07502271A (ja) 1995-03-09
CA2085687A1 (fr) 1993-06-20
US5254549A (en) 1993-10-19
HU215844B (hu) 1999-04-28
AU3159293A (en) 1993-07-19
WO1993012089A1 (fr) 1993-06-24

Similar Documents

Publication Publication Date Title
NO955034L (no) Nye substituerte 1H-imidazoler og farmasöytiske preparater inneholdende disse
DK1023900T3 (da) Farmaceutisk præparat indeholdende S-nitroso-lipoproteiner og anvendelse deraf
DK0470514T3 (da) Carbostyrilderivater og farmaceutiske præparater indeholdende disse
FI922958L (fi) Farmaceutisk sammansaettning
FI922316L (fi) Farmaceutisk sammansaettning
FI922252L (fi) Farmaceutisk sammansaettning
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
NO933644D0 (no) Vaskemiddelblanding inneholdende polyvinyl-pyrrolidon og enzymer
DK0585252T3 (da) Farmaceutiske formuleringer
FI923582L (fi) Farmaceutisk sferoidkomposition
DK0847391T3 (da) Aromatiske forbindelse og farmaceutiske præparater indeholdende disse
NO302293B1 (no) Isokinolinforbindelser og farmasöytisk preparat omfattende en sådan forbindelse
BR9200058A (pt) Composto e composicao farmaceutica
ITRM910952A0 (it) Composizioni farmaceutiche contenenti gonadotropine
NO301473B1 (no) BHT-omega-pyridyleterforbindelser og farmasöytisk preparat inneholdende disse
FI920079A7 (fi) Suorakulmainen liitos
MX9200622A (es) Composicion farmaceutica
DE69227976D1 (de) Amphotere Zusammensetzungen
DK162640C (da) N-piperazinylalkanoylanilider og farmaceutiske kompositioner, der indeholder disse forbindelser
FI943705L (fi) Farmaseuttiset koostumukset
DK0508334T3 (da) Aminophenolderivater og farmaceutiske præparater indeholdende disse
NO305943B1 (no) Klorfluoretersammensetninger og preparater av disse
FI962979A7 (fi) Hirudiinia sisältävät farmaseuttiset koostumukset
NO943236D0 (no) Nye 1,2-ditiol-3-tionderivater og farmasöytisk preparat inneholdende disse